Laser Treatment for Acne

N/A

Waitlist Available

Led By Dieter Manstein, MD, PhD

Research Sponsored by Massachusetts General Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Ages 18 through 40

Ages 18 through 40;

Must not have

Currently take oral antibiotic or oral therapy for acne

History of poor wound healing

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change in pga score between baseline visit and post procedural visit

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing a laser to see if it can help people with moderate to severe acne.

Who is the study for?

This trial is for individuals aged 18-40 with moderate to severe nodular acne (PGA 3 or 4) who haven't responded to standard treatments. Participants must be in good health, willing to avoid sun exposure on treated areas, and not pregnant or breastfeeding. They shouldn't have had laser treatment or isotretinoin therapy recently.

What is being tested?

The study tests a commercial laser's effectiveness in treating moderate to severe acne vulgaris. It aims to see if the laser can improve skin condition in those who've declined conventional therapies like oral isotretinoin.

What are the potential side effects?

Potential side effects may include discomfort during treatment, redness, swelling, and temporary changes in skin pigmentation. There's also a risk of scarring and poor wound healing for some individuals.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 40 years old.

Select...

I am between 18 and 40 years old.

Select...

I cannot take or have chosen not to take standard treatments like oral isotretinoin.

Select...

I have moderate to severe acne on my face.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am currently taking medication for acne.

Select...

I have a history of wounds healing poorly.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change in pga score between baseline visit and post procedural visit

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change in pga score between baseline visit and post procedural visit

This trial's timeline: 3 weeks for screening, Varies for treatment, and change in pga score between baseline visit and post procedural visit for reporting.